ProtoPulse · CNAS therapeutic protocols
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
Data updated 19 Oct 2026, 22:37 · printed from ProtoPulse
OCRELIZUMABUM
Active substance (INN) · ATC L04AG08 · 2 products authorised in Romania
1
Protocols it appears in
As a medicine of the protocol (in the title) or only mentioned in the text
| Code | Protocol | Status | Role | Sublist | GP |
|---|---|---|---|---|---|
| L002G | SCLEROZA MULTIPLĂ - TRATAMENT IMUNOMODULATOR | In force | mentioned in the text | C2-P4 | NO |
2
Authorised brand products (ANMDM)
The Romanian register of medicines for human use, updated daily
| Brand name | Form | Strength | Holder | ATC | Rx |
|---|---|---|---|---|---|
| OCREVUS 300 mg | CONC. PT. SOL. PERF. | 30mg/ml | ROCHE REGISTRATION GMBH - GERMANIA | L04AG08 | PR |
| OCREVUS 920 mg | SOL. INJ. | 40mg/ml | ROCHE REGISTRATION GMBH - GERMANIA | L04AG08 | PR |